Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.63 USD | -1.15% | +9.10% | +111.52% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.93B |
---|---|---|---|---|---|
Net income 2024 * | -292M | Net income 2025 * | -277M | EV / Sales 2024 * | - |
Net Debt 2024 * | 10.59M | Net cash position 2025 * | 190M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.65
x | P/E ratio 2025 * |
-7.78
x | Employees | 328 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.37% |
Latest transcript on Sana Biotechnology, Inc.
1 day | +2.17% | ||
1 week | +15.48% | ||
Current month | -3.00% | ||
1 month | +14.72% | ||
3 months | +0.58% | ||
6 months | +107.86% | ||
Current year | +113.97% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 8.63 | -1.15% | 1 117 883 |
24-05-17 | 8.73 | +2.11% | 1,264,834 |
24-05-16 | 8.55 | -7.77% | 1,126,685 |
24-05-15 | 9.27 | +7.79% | 1,494,014 |
24-05-14 | 8.6 | +8.72% | 2,359,896 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.97% | 1.93B | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- SANA Stock